TRPM3 as novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain
Vincenzo Davide Aloi, Sílvia Pinto, Rita van Bree, Katrien Luyten, Thomas Voets, Joris Vriens
This study identifies TRPM3 as a potential therapeutic target for acute oxaliplatin-induced neuropathic pain by showing its role in pain behaviors and neuronal activity.
Pain · Apr 19, 2023Peer-reviewedNeuroscience